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Introduction
Bluetongue and epizootic hemorrhagic disease are hemor-
rhagic diseases of ruminants caused by Bluetongue virus 
(BTV) and Epizootic hemorrhagic disease virus (EHDV), 
respectively. Bluetongue virus and EHDV (family Reoviri-
dae, subfamily Sedoreovirinae, genus Orbivirus) have seg-
mented genomes composed of 10 segments of double-stranded 
RNA that encode 7 structural and 4 nonstructural proteins. 
The segmented viral genomes facilitate reassortment with 
different serotypes during coinfection with other viruses of 
the same species.30,46 Serotypes are determined by the viral 
protein 2 (VP2), an outer capsid protein. To date, 26 sero-
types of BTV and 7 serotypes of EHDV have been identi-
fied.4,10,20 Until 1998, only BTV serotypes 2, 10, 11, 13, and 
17 were present in the United States. Since then, an addi-
tional 10 serotypes (1, 3, 5, 6, 9, 12, 14, 19, 22, and 24) have 
been identified, primarily in the southern areas of the United 
States.25 As for EHDV, 2 strains were endemic to the United 
States (EHDV-1, New Jersey strain, and EHDV-2, Alberta 
strain).12,34 However, in 2006, an exotic strain of EHDV-6 
was isolated from white-tailed deer (Odocoileus virginianus) 
in Indiana and Illinois.1 The virus has since been identified 
throughout the midwestern, eastern, and southern United 
States.1,2
Both BTV and EHDV are noncontagious viruses spread 
by biting Culicoides midges. The viruses are endemic in geo-
graphical locations with temperate, subtropical, and tropical 
climates (i.e., areas where the insect vector is present and 
capable of spreading disease).20,30,46 Wild and domestic 
ruminants, including sheep, cattle, and white-tailed deer are 
susceptible to BTV and EHDV. Clinical disease from BTV 
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Abstract. Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) possess similar structural and molecular 
features, are transmitted by biting midges (genus Culicoides), and cause similar diseases in some susceptible ruminants. 
Generally, BTV causes subclinical disease in cattle, characterized by a prolonged viremia. EHDV-associated disease in cattle is 
less prominent; however, it has emerged as a major economic threat to the white-tailed deer (Odocoileus virginianus) industry 
in many areas of the United States. The recent emergence of multiple BTV and EHDV serotypes previously undetected in the 
United States demonstrates the need for robust detection of all known serotypes and differential diagnosis. For this purpose, a 
streamlined workflow consisting of an automated nucleic acid purification and denaturation method and a multiplex one-step 
reverse transcription quantitative polymerase chain reaction for the simultaneous detection of BTV serotypes 1–24 and EHDV 
serotypes 1–7 was developed using previously published BTV and EHDV assays. The denaturation of double-stranded (ds) 
BTV and EHDV RNA was incorporated into the automated nucleic acid purification process thus eliminating the commonly 
used separate step of dsRNA denaturation. The performance of this workflow was compared with the World Organization 
of Animal Health BTV reference laboratory (National Veterinary Services Laboratory, Ames, Iowa) workflow for BTV and 
EHDV detection, and high agreement was observed. Implementation of the workflow in routine diagnostic testing enables 
the detection of, and differentiation between, BTV and EHDV, and coinfections in bovine blood and cervine tissues, offering 
significant benefits in terms of differential disease diagnosis, herd health monitoring, and regulated testing.
Key words: Bluetongue virus; Epizootic hemorrhagic disease virus; polymerase chain reaction.
 Schroeder et al.710
and/or EHDV infection is most often seen in white-tailed 
deer and includes fever, excessive salivation and nasal dis-
charge, and hemorrhaging from oral and nasal tissue.46 Sero-
types of BTV found in the United States do not typically 
cause clinical disease in cattle.25 However, exotic BTV sero-
types are known to cause clinical signs, and occasionally 
clinical signs are also seen with U.S. serotypes. In late sum-
mer through early fall of 2012, a significant number of epi-
zootic hemorrhagic disease cases in cattle were confirmed in 
the northern U.S. states of Nebraska, South Dakota, Wyo-
ming, and Iowa, and it is believed that the disease was spread 
from deer to cattle by insect vectors (Wilson D: 2013, Epizo-
otic hemorrhagic disease update. Calif Vet Jan/Feb: 44–45). 
In general, cattle most often act as reservoirs for BTV and 
EHDV due to a prolonged cell-associated viremia, which 
contributes significantly to the epidemiology of the disease.46
Bluetongue virus and EHDV infections can have a nega-
tive economic impact on the cattle and deer industry.19,30,41,46 
The emergence of exotic strains of BTV and EHDV, as well 
as the appearance of EHDV in cattle in northern states, dem-
onstrates the emerging and dynamic nature of these viruses 
and the potential increasing impact on the economy. Eco-
nomic impact includes loss of infected animals, trade restric-
tions imposed on the movement of animals and/or livestock 
and their products (i.e., semen and ova), and testing 
costs.19,27,30 Because of the negative economic consequences 
of BTV and EHDV infection, the World Organization for 
Animal Health (OIE) has established recommendations for 
international trade in order to prevent the spread of these 
viruses to nonaffected countries.46
Several reverse transcription polymerase chain reaction 
(RT-PCR) assays, targeting various viral proteins, have been 
developed for the detection of BTV and EHDV.5,17,43,44 
Because the viral genomes are composed of double-stranded 
RNA (dsRNA), a denaturation step is included prior to 
nucleic acid amplification. There are currently several meth-
ods in use for denaturation of the dsRNA genome, including 
heat denaturation at 95°C (for 1–8 min) with or without 
dimethyl sulfoxide15,40,41 and the use of various chemicals 
such as methylmercury (II) hydroxide,3,45 trehalose,11,13,37 
tetramethylene sulfoxide,11,13 and betaine.13,36 While these 
methods are successful at enhancing amplification of BTV 
and EHDV, they are labor intensive and create the potential 
for contamination, as they require an additional step follow-
ing nucleic acid purification and prior to PCR amplification. 
In addition, several of the methods require the use of hazard-
ous chemicals.
Therefore, an innovative streamlined workflow that 
incorporates the denaturation of the viral dsRNA into the 
nucleic acid purification was developed in order to eliminate 
the separate step of dsRNA denaturation commonly used for 
enhanced PCR sensitivity. The workflow consisted of an 
automated nucleic acid purification and denaturation method 
and a BTV and EHDV multiplex one-step quantitative RT-
PCR (mRT-qPCR) for the simultaneous detection of BTV 
serotypes 1–24 (BTV serotypes 25–26 were not tested with 
this workflow because these viruses were unavailable) and 
EHDV serotypes 1–7. The performance of this workflow 
was assessed by comparison with the OIE BTV reference 
laboratory (http://www.oie.int/; the National Veterinary Ser-
vices Laboratory [NVSL; Ames, Iowa]) workflow for detec-
tion of BTV and EHDV. Following successful performance 
evaluation, the workflow was implemented at the Texas 
A&M Veterinary Medical Diagnostic Laboratory (TVMDL; 
College Station, Texas) for diagnostic testing of greater than 
3,000 samples during a 1-year testing period.
Methods and materials
Virus reference strains
Viral stocks or BTV RNA of serotypes 1–24 were obtained 
from the NVSL. Epizootic hemorrhagic disease virus sero-
types 1 and 2 were obtained from the NVSL, while RNA for 
EHDV serotypes 3–7 was kindly provided by the Arthropod-
Borne Animal Diseases Research Unit, Center for Grain and 
Animal Health Research, Agricultural Research Service, 
U.S. Department of Agriculture (Manhattan, Kansas).
Samples for performance evaluation
For the automated nucleic acid purification and RNA dena-
turation evaluation, the following samples were used: 20 
BTV-only positive bovine blood samples, 37 (14 blood and 
23 tissue) EHDV-only positive samples, and 33 (30 blood 
and 3 tissue) BTV and EHDV–positive samples; positive 
samples were defined by mRT-qPCR. For TVMDL work-
flow diagnostic sensitivity and specificity determination 
using the NVSL workflow as the reference method, a total of 
125 bovine blood samples (consisting of BTV, EHDV, and 
BTV and EHDV positives and negatives) were used. Addi-
tionally, 126 BTV and EHDV–negative blood samples from 
the presumed BTV and EHDV–free state of Wisconsin (con-
firmed by PCR by the Wisconsin Veterinary Diagnostic 
Laboratory [WVDL; Madison, Wisconsin]) were used to 
verify assay specificity.
TVMDL workflow
An in vitro transcribed BTV and EHDV control RNA, con-
taining the target sequences for BTV and EHDV, and an in 
vitro transcribed exogenous internal positive control (XIPC) 
RNA were generated for mRT-qPCR optimization. DNA 
sequences specific to BTV and EHDV, as well as XIPC, 
were chemically synthesized and cloned into a plasmid vec-
tor by a commercial company.a Plasmids were linearized 
using HindIII restriction enzyme digestion and subsequently 
transcribed into RNA using a commercial transcription kit.b 
In vitro transcription was performed according to the manu-
facturer’s instructions. In vitro transcripts were quantitated 
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using a spectrophotometer,c and sizes were verified by 
electrophoresis.d
The TVMDL oligonucleotides sequence information and 
the final reaction concentrations in the 25-µl mRT-qPCR are 
provided in Table 1. Primer and probe sequences for detec-
tion of BTV, EHDV, and XIPC were adopted from previous 
publications.14,16,31 The synthetic construct clone NISTag38 
external RNA control sequence (GenBank accession no. 
DQ883679) is a unique artificial antigenomic sequence with 
no significant homology to annotated species sequences. 
This sequence was used as the XIPC target. All primers and 
probes were purchased from a commercial source.e
Nucleic acid was purified from all samples at TVMDL 
using a commercial RNA isolation kit.b Briefly, a 50-µl 
blood sample, or a 50-µl tissue homogenate (10% weight/
volume in 1× phosphate buffered saline), was transferred to 
a 96-well, deep-well plate containing 20 µl of magnetic bead 
mix (10 µl of lysis/binding enhancer and 10 µl of RNA bind-
ing beads), and 400 µl of lysis binding solution (containing 
200 µl of lysis binding concentrate, 1 µl of carrier RNA [1 
µg/µl], 1 µl of XIPC RNA [at 10,000 copies/µl] and 200 µl of 
100% isopropanol) was added. This plate was denoted as the 
sample plate. The following four 96-well plates were loaded 
onto an automatic particle processorc for nucleic acid purifi-
cation: sample plate, wash solution 1 plate (300 µl/well), 
wash solution 2 plate (300 µl/well), and elution buffer plate 
(90 µl/well). The nucleic acid purification procedure con-
sisted of the following steps: lysis/binding for 5 min, one 
60-sec wash 1, one 15-sec wash 2, 1-min dry step, and a 
3-min heated elution step at 70°C or 95°C. For those samples 
that were eluted at 70°C, all liquid was transferred to a PCR 
plate, and then denatured at 95°C for 5 min on a thermal 
cyclerf immediately following elution. All samples were 
immediately placed on ice following denaturation.
The TVMDL mRT-qPCR utilized the components of a 
commercial RT-PCR kitb (according to manufacturer’s 
instructions) and the primers and probes for detection of BTV, 
EHDV, and the XIPC; the final concentration of each oligo-
nucleotide is provided in Table 1. Each reaction contained 
12.5 µl of 2× multiplex RT-PCR buffer, 2.5 µl of 10× multi-
plex enzyme mix, 1 µl of 25× primer probe mix (containing all 
the oligonucleotides in Table 1), 1 µl of nuclease-free water, 
and 8 µl of nucleic acid template for a total volume of 25 µl. 
The RT-qPCR was performed using a real-time PCR system.b 
The cycling conditions were as follows: reverse transcription 
at 48°C for 10 min (single cycle), activation/denaturation at 
95°C for 10 min (single cycle), and 40 cycles of amplification 
at 95°C for 15 sec and 55°C for 45 sec. For diagnostic sensitiv-
ity and specificity determination using the NVSL workflow as 
the reference method, samples with a quantification cycle (Cq) 
≤36.0 cycles were considered positive for BTV, while samples 
with a Cq ≤40.0 cycles were considered positive for EHDV.
NVSL (OIE BTV reference laboratory) 
workflow
The sequences of the oligonucleotides used in the nested PCR 
(nPCR) are provided in Table 2. Primer sequences for detec-
tion of BTV and EHDV were obtained from previous publi-
cations.18,42 Nucleic acid was purified at the NVSL using a 
commercial reagent per the manufacturer’s instructions.g 
Each purified nucleic acid sample was resuspended in 25 µl 
of RNase-free water, 5 µl was transferred to a PCR tube, and 
the samples were heated at 95°C for 10 min on a thermal 
cyclerb to denature the dsRNA. Samples were cooled at 4°C 
prior to use in the RT-PCR.
The final concentrations (per reaction) of the oligonucle-
otides for BTV and EHDV in the RT-PCR and secondary 
Table 1. Primers and probes for the Bluetongue virus and Epizootic hemorrhagic disease virus multiplex reverse transcription 
polymerase chain reaction assays.*
Oligonucleotide Sequence (5′–3′) and reporter dye
Amplicon 
size (bp)
Final 25-µl reaction 
concentration (nM)
Target 
region Reference
Bovine Bluetongue virus
 BTVpan_Fprm_H TGGAYAAAGCGATGTCAAA  96 450 NSP3 16
 BTVpan_Rprm_H ACATCATCACGAAACGCTTC 450
 BTVpan_pb FAM-ARGCTGCATTCGCATCGTACGC-BHQ1 100
Epizootic hemorrhagic disease virus
 EHD_F ACWGGVATCATGTTTGAGCT 110 450 NSP1 14
 EHD_R TTCATAACCGCACCTTCATC 450
 EHD_pbI VIC-TCATCACACATCGGC-MGB 60
 EHD_pbII VIC-TCTCGGCATATGCGAGC-MGB 60
Exogenous internal positive control
 XIPC F TTCGGCGTGTTATGCTAACTTC 69 200 NA 31
 XIPC R CCACTGCGCCCAACCTT 200
 XIPC pb TAM-CTCCGCAGAAATCCAGGGTCATCG-BHQ2 125
* FAM = 6-carboxyfluorescein; BHQ1, BHQ2 = black hole quencher 1 and 2, respectively; MGB = minor groove binder; NSP = nonstructural protein; 
NA = not applicable.
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nPCR are provided in Table 2. Each RT-PCR reaction con-
tained 27.0 µl of RNase-free water, 5.0 µl of 10× PCR buffer 
(100 mM Tris–HCl, pH 8.3, 500 mM KCl),b 4.0 µl of 25 mM 
MgCl
2
,b 4.0 µl of 10 mM deoxyribonucleotide triphosphate 
(dNTP) mix,b 0.4 µl of RT enzyme (200 units/µl),g 0.125 µl 
of RNase inhibitor (10 units/µl),g 0.5 µl of DNA polymerase 
(5 units/µl),b and 4.0 µl of outer primers A and B (30–40 
pmol of each primer for BTV or EHDV). Denatured tem-
plate (5 µl) was mixed with 45 µl of the RT-PCR mixture and 
amplified using a thermocycler.f The RT-PCR cycling condi-
tions were as follows: 44°C for 50 min, 95°C for 10 min, 35 
cycles of amplification at 95°C for 25 sec, 60°C for 20 sec, 
and 72°C for 25 sec, with a final 5-min extension at 72°C, 
followed by refrigeration. The secondary PCR reaction 
(nPCR) contained 32.0 µl of RNase-free water, 5.0 µl of 10× 
PCR buffer (100 mM Tris–HCl, pH 8.3, 500 mM KCl),b 3.5 
µl of 25 mM MgCl2,
b 4.5 µl of 10 mM dNTP mix,b 0.5 µl of 
DNA polymerase (5 units/µl),b and 4.0 µl of nested primers 
C and D (20–30 pmol of each primer for BTV or 30–40 pmol 
of each primer for EHDV). The initial RT-PCR amplicon 
(1.5 µl) was mixed with 48.5 µl of the nPCR mixture. The 
cycling conditions for the nPCR were as follows: 95°C for 
10 min (single cycle), 35 cycles of amplification at 95°C for 
20 sec, 60°C for 20 sec, 72°C for 20 sec, with a final 5 min 
hold at 72°C, followed by refrigeration.
Amplified PCR products were visualized on a 2.5–3% 
agarose gel.h Amplified DNA products (8–10 µl) were mixed 
with 3 µl of DNA loading buffer containing a DNA stain,i 
loaded onto the gel, and run at 65–80 V for 1–1.5 hr. Bands 
were visualized under ultraviolet light. All samples were 
tested in duplicate, and only those samples containing bands 
of the correct size (101 bp for BTV and 138 bp for EHDV) 
for both duplicates were considered positive.
Statistical analysis
Regression analysis was performed using statistical soft-
warej to assess correlation between the automated RNA 
denaturation and thermal cycler denaturation. Probit analy-
sis was performed using statistical software j to assess the 
limit of detection of each assay.8,9,35 Repeatability of the 
mRT-qPCR was determined by calculation of the intra- and 
interassay coefficient of variation (CV) for each pathogen 
assay. Intra-assay variability was analyzed in triplicate 
PCR at each dilution, and interassay variability was ana-
lyzed in 3 separate experiments (runs). Intra-assay CV = 
[(average of each run’s Cq standard deviation (SD)/average 
of each run’s Cq average) × 100]; interassay CV = [(SD of 
the averages of each run/average of the averages of each 
run) × 100].
Performance of the TVMDL workflow for the detection 
of BTV and EHDV was evaluated by comparison against 
the NVSL method using a panel of 125 positive and nega-
tive blood samples. Cohen’s kappa and percentage agree-
ment were calculated using a previously published 
method.24
Results
Automated 95°C denaturation versus separate 
thermal cycler 95°C denaturation
The performance of the automated 95°C denaturation was 
compared to the separate thermal cycler 95°C denatur-
ation using 90 positive samples consisting of 20 BTV-
only positive, 37 EHDV-only positive, and 33 BTV and 
EHDV–positive samples. The automated 95°C denatur-
ation produced equivalent or lower Cq values to the ther-
mal cycler denaturation (Supplemental Fig. 1A, 1B). The 
XY scatter plots of thermal cycler denaturation Cq values 
versus the automated denaturation Cq values showed a 
good correlation between the 2 denaturation methods 
(Fig. 1A, 1B). Correlation coefficients for BTV and 
EHDV were 0.9655 and 0.9438 (P values <0.0001 for 
both), respectively, indicating that the 2 methods pro-
duced equivalent Cq values.
Table 2. Primers for the Bluetongue virus and Epizootic hemorrhagic disease virus nested reverse transcription polymerase chain 
assays.*
Oligonucleotide Sequence (5′–3′)
Amplicon 
size (bp)
Final 50-µl reaction 
concentration (nM)
Target 
region Reference
Bluetongue virus
 A (BT10) GTTCTCTAGTTGGCAACCACC 101 600–800 NSP1 18
 B (BT283c) AAGCCAGACTGTTTCCCGAT 600–800
 C (BT169) GCAGCATTTTGAGAGAGCGA 400–600
 D (BT269c) CCCGATCATACATTGCTTCCT 400–600
Epizootic hemorrhagic disease virus
 A (EHD8) AAGTTCTTCGTCGACTGCCATC 138 600–800 NSP1 42
 B (EHD449c) GGTTGCACCATCTGGCCATAAT 600–800
 C (EHD98) AGCATTATCACCACAGTGGACG 600–800
 D (EHD235c) GCCAATCTATATGCCGCATGT 600–800
* NSP = nonstructural protein.
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Intra- and interassay repeatability and 
analytical sensitivity of BTV and EHDV assays
Triplicate mRT-qPCR assays in 3 separate experiments 
were performed in order to assess the intra- and interassay 
repeatability for the TVMDL BTV and EHDV assays as 
well as the analytical sensitivity using probit analysis. 
The CV within runs (intra-assay variability) ranged from 
0.4% to 5.3% for BTV and 0.4% to 2.2% for EHDV; 
between runs (interassay variability) ranged from 1.1% to 
5.4% for BTV and 0.5% to 1.8% for EHDV (Supplemen-
tal Table 1). Serial dilutions of an in vitro transcribed 
BTV and EHDV control RNA and XIPC RNA (1,000 cop-
ies/reaction) were used to estimate the analytical sensitiv-
ity of each assay. Probit analysis was performed for each 
assay in order to determine the 95% mRT-qPCR detection 
rate. The data sets for the last 5 purified nucleic acid dilu-
tions of the intra- and interassay variability experiment 
were used for the analysis. A total of 9 reactions 
(responses) were used for each BTV- and EHDV-purified 
nucleic acid dilution; Cq values below 40 were considered 
a positive response or amplification. Copy number equiv-
alents for the pathogen-purified nucleic acid dilutions 
were estimated using the mRT-qPCR targeting serial dilu-
tions of BTV and EHDV control RNA and subsequent 
standard curve data analysis. The mRT-qPCR detection 
limit was less than 200 BTV target copies and less than 
100 EHDV target copies per PCR for both assays, as 
determined by probit analysis. The probit graph (probabil-
ity vs. log
10
 [dose] EHDV-purified nucleic acid) for 
EHDV is displayed in Figure 2 (similar results were 
obtained for BTV, data not shown).
Analysis of diagnostic samples: comparison of 
NVSL and TVMDL workflows
The performance of the TVMDL workflow was evaluated 
for the detection of BTV and EHDV using a selection of 125 
bovine blood samples submitted to the TVMDL. The sam-
ples were tested by the TVMDL and NVSL workflows. The 
Figure 1. Correlation of the automated 95°C denaturation versus the separate thermal cycler 95°C denaturation of Bluetongue virus 
(BTV) and Epizootic hemorrhagic disease virus (EHDV) purified RNA. The XY scatter plots of the quantification cycle (Cq) values for the 
thermal cycler denaturation versus the Cq values for the automated denaturation showed a good correlation between the 2 methods. A, BTV 
assay; B, EHDV assay.
Figure 2. Probit analysis of Epizootic hemorrhagic disease 
virus (EHDV) detection by the multiplex reverse transcription 
polymerase chain reaction assay. Serial dilutions of EHDV purified 
nucleic acid were prepared in pathogen-negative bovine blood 
nucleic acid and used for probit analysis. A total number of 9 
responses for each nucleic acid dilution were analyzed in order to 
determine the nucleic acid dilution corresponding to a detection rate 
of 95%. Similar results were obtained for Bluetongue virus.
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NVSL (OIE BTV reference laboratory) workflow was 
selected as the reference method for diagnostic sensitivity 
and specificity analysis (Table 3). The NVSL workflow 
identified 24 (19%) BTV-only positives, 19 (15%) EHDV-
only positives, 35 (28%) both BTV and EHDV positives, and 
47 (38%) negatives (both BTV and EHDV).
The TVMDL workflow produced equivalent and reliable 
results. The internal positive control, XIPC RNA, was 
detected in all samples (average Cq = 31.8 ± 0.5), indicating 
effective nucleic acid purification and amplification. For the 
24 NVSL workflow BTV-only positives, the TVMDL work-
flow identified all 24 BTV positives (perfect agreement); 21 
were identified as BTV-only positive and 3 as both BTV and 
EHDV positive (EHDV Cq values = 33.5, 34.6, 38.8). For 
the 19 NVSL workflow EHDV-only positives, the TVMDL 
workflow identified all 19 positives (perfect agreement). For 
the 35 NVSL workflow samples that were both BTV and 
EHDV positive, the TVMDL workflow identified 30 as both 
BTV and EHDV positive, 2 as BTV-only positive (with no 
EHDV amplification, Cq values = 0), and 3 as EHDV-only 
positive. For the 3 EHDV-only positives, BTV amplification 
was positive with Cq values > 36.0 (Cq values = 39.7, 37.6, 
37.2), which was greater than the Cq cutoff value established 
for identification as BTV positive as determined based on 
assay repeatability analysis. Thus, these samples were identi-
fied as BTV negative.
Lastly, for the 47 NVSL workflow negatives (both BTV 
and EHDV), the TVMDL workflow identified 4 as EHDV-
only positive (Cq values = 31.8, 32.4, 35.1, 37.0). The 
TVMDL workflow agreement with the NVSL workflow 
defined “positive” for BTV-only positives was 100% (κ = 
1.00, almost perfect), for EHDV-only positives was 94% 
(κ = 0.86, almost perfect), and both BTV and EHDV posi-
tives was 94% (κ = 0.87, almost perfect; Table 3). The agree-
ment for identification of all BTV positives and all EHDV 
positives, irrespective of single pathogen or dual pathogen 
positive classification, was calculated to be 98% (κ = 0.95, 
almost perfect) and 93% (κ = 0.85, almost perfect), respec-
tively (Table 4). This same sample panel was also tested with 
singleplex BTV or EHDV RT-qPCR, and comparable results 
with mRT-qPCR were obtained (data not shown) supporting 
the use of the mRT-qPCR assay. For additional workflow 
specificity assessment, 126 BTV and EHDV–negative blood 
samples from the presumed BTV and EHDV–free state of 
Wisconsin (samples were confirmed negative by PCR by 
WVDL) were tested and confirmed to be negative using the 
TVMDL workflow.
Analysis of TVMDL diagnostic samples
On completion of the successful performance evaluation 
study, the TVMDL workflow was implemented for routine 
testing of diagnostic samples submitted to the laboratory for 
regulatory requirements, herd health management, and 
clinical diagnosis. Over the course of 1 year (December 
2011–December 2012), approximately 3,043 samples con-
sisting of bovine, ovine, caprine, and cervine specimens (i.e., 
blood, tissue, and semen) were tested as diagnostic submis-
sions (Table 5). A total of 376 positives (approximately 
12.4% positive rate) were identified; specifically, 157 BTV-
only positives (5.2% positive rate), 176 EHDV-only posi-
tives (5.8%), and 43 both BTV and EHDV positives (1.2%). 
Bluetongue virus and EHDV coinfections were observed at 
an 11.4% rate (of all positives, 43/376).
Table 3. Performance comparison of the Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL; College Station, Texas) 
and the National Veterinary Services Laboratory (NVSL; Ames, Iowa) workflows for the detection of Bluetongue virus (BTV) positive 
only, Epizootic hemorrhagic disease virus (EHDV) positive only, and both BTV- and EHDV-positive samples.*
TVMDL
AgreementNSVL Positive Negative Total Sensitivity (%) Specificity (%) Kappa
BTV  
 Positive 24 0 24 100.0 (95%  
CI: 0.86–1.00)
100.0 (95%  
CI: 0.92–1.00)
1.00 (95% CI: 1.00–1.00; 
almost perfect)
1.00 (95%  
CI: 0.95–1.00)
 Negative 0 47 47  
 Total 24 47 71  
EHDV  
 Positive 19 0 19 100.0 (95%  
CI: 0.82–1.00)
91.0 (95%  
CI: 0.80–0.98)
0.86 (95% CI: 0.73–0.99; 
almost perfect)
0.94 (95%  
CI: 0.85–0.98)
 Negative 4 43 47  
 Total 23 43 66  
BTV and EHDV  
 Positive 30 5 35 86.0 (95%  
CI: 0.70–0.95)
100.0 (95%  
CI: 0.92–1.00)
0.87 (95% CI: 0.76–0.98; 
almost perfect)
0.94 (95%  
CI: 0.86–0.98)
 Negative 0 47 47  
 Total 30 52 82  
* 95% CI = 95% confidence interval.
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Of the 157 BTV-only positives, 103 were from bovine 
blood, 48 were from cervine tissues, and the remaining 6 
were from ovine, caprine, or unknown sources; the cervine 
positive tissues consisted of mainly spleen (32/48, approxi-
mately 67%), while other tissues such as tonsil, lung, testes, 
and lymph node represented a minor set of positive tissue 
samples. Limited clinical hemorrhagic disease information 
was provided in the submissions thus correlation of infection 
with disease was not possible. However, it is interesting to 
note that of the BTV-only positive samples, 2 bovine blood 
samples and 37 cervine tissue samples (approximately 77% 
of 48 BTV-only cervine tissue positives) were from animals 
with clinical hemorrhagic disease; the remaining 112 sam-
ples (101 bovine and 11 cervine) lacked clinical disease 
information.
Of the 176 EHDV-only positives, 124 were from cervine 
blood (n = 18) and tissue (n = 106), 36 were from bovine 
blood, and the remaining 16 were from caprine tissue (n = 
14), ovine (n = 1), or unknown sources (n = 1). The majority 
of positive tissue samples (96/120, 80%) were spleen, similar 
to the BTV positive tissues. All 36 bovine samples and 41 
cervine samples lacked clinical disease information. How-
ever, 83 of the 124 total cervine EHDV-only positives 
(approximately 67%) were from animals with clinical disease
Interestingly, of the 43 both BTV and EHDV–positive 
samples identified, 34 were from bovine blood samples. Two 
of these 34 coinfected bovine samples were from animals 
with clinical signs; both animals were from farms reporting a 
BTV and/or EHDV outbreak; the remaining 32 samples 
lacked disease information. The other 9 BTV and EHDV 
copositive samples were from cervine tissues (spleen, testes, 
tonsil, and salivary gland), 5 of which were from animals with 
disease, while 4 were samples submitted without disease 
information. Neither BTV nor EHDV was detected in any of 
the semen (n = 454) samples submitted for diagnostic testing.
Discussion
Bluetongue virus and EHDV are 2 viral diseases of economic 
importance to the cattle and white-tailed deer industry in the 
Table 4. Performance comparison of the Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL; College Station, Texas) 
and the National Veterinary Services Laboratory (NVSL; Ames, Iowa) workflows for the detection of all Bluetongue virus (BTV)–positive 
samples and all Epizootic hemorrhagic disease virus (EHDV)–positive samples, irrespective of single pathogen or dual pathogen positive 
classification.*
TVMDL
AgreementNVSL Positive Negative Total Sensitivity (%) Specificity (%) Kappa
BTV  
 Positive 56 3 59 95.0 (95%  
CI: 0.86–0.99)
100.0 (95%  
CI: 0.95–1.00)
0.95 (95% CI: 0.90–1.00; 
almost perfect)
0.98 (95%  
CI: 0.93–1.00)
 Negative 0 66 66  
 Total 56 69 125  
EHDV  
 Positive 52 2 54 96.0 (95%  
CI: 0.87–1.00)
90.0 (95%  
CI: 0.81–0.96)
0.85 (95% CI: 0.76–0.95; 
almost perfect)
0.93 (95%  
CI: 0.87–0.97)
 Negative 7 64 71  
 Total 59 66 125  
* 95% CI = 95% confidence interval.
Table 5. Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) diagnostic submissions and outcomes over a 
1-year period (n = 3,043 samples total).
No. of submissions BTV-only positive EHDV-only positive
BTV and EHDV 
positive
Species Blood Semen Tissue Blood Tissue Blood Tissue Blood Tissue
Bovine 1,812 453 20 103 0 36 0 34 0
Caprine 24 0 34 1 1 0 14 0 0
Cervine 73 0 542 1 47 18 106 0 9
Ovine 47 0 6 0 2 1 0 0 0
Unknown 29 1 2 2 0 1 0 0 0
Total 1,985 454 604 107 50 56 120 34 9
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United States.19,41,46 Identification of these viruses is impor-
tant in order to evaluate their distribution and epidemiology. 
The current available reference laboratory PCR method for 
the detection of BTV and EHDV involves 2 separate nPCR 
reactions, 1 for each virus.46 Additionally, in order to enhance 
sensitivity, the purified double-stranded viral RNA is dena-
tured in a separate step following nucleic acid purification 
and prior to PCR amplification.13,27,40 The dsRNA denatur-
ation step, however, is time consuming, requires the use of 
hazardous chemicals, and can create the potential for con-
tamination and human error due to additional pipetting steps. 
In order to reduce potential errors and possible contamina-
tion from these additional pipetting steps, an innovative 
streamlined workflow was developed for the rapid denatur-
ation and subsequent detection of BTV (serotypes 1–24) and 
EHDV (serotypes 1–7). Denaturation (95°C for 3 min) of the 
viral dsRNA was incorporated into the elution step of the 
automated particle processorc program. Therefore, the viral 
nucleic acid was denatured during nucleic acid purification, 
thus eliminating the need for a separate denaturation step 
prior to RT-qPCR amplification.
Comparison of the automated 95°C denaturation method 
and the commonly used separate thermal cycler 95°C dena-
turation step method demonstrated that the automated dena-
turation method produced equivalent or lower Cq results for 
the detection of BTV and EHDV. Correlation coefficients of 
0.9655 and 0.9438 (P values <0.0001 for both) for BTV and 
EHDV, respectively, revealed a strong correlation between 
both denaturation methods.
The streamlined workflow presented herein, consisting of 
automated denaturation and purification followed by BTV 
and EHDV mRT-qPCR amplification, was assessed against 
the thermal cycler denaturation and nPCR workflow per-
formed at the NVSL, an OIE BTV reference laboratory. 
When compared with the NVSL workflow, the TVMDL 
workflow showed a diagnostic sensitivity of 95.0% for BTV 
positives and 96% for EHDV positives, and a diagnostic 
specificity of 100.0% for BTV-positive and 90.0% for 
EHDV-positive samples, respectively, irrespective of single 
pathogen or dual pathogen positive classification. Overall, 
the results demonstrate very good agreement between the 2 
workflows and greater than 95% sensitivity for the TVMDL 
workflow, thus providing support for the applied utility of 
this method for BTV and EHDV detection. Practical advan-
tages of the TVMDL workflow include dsRNA denaturation 
during the automated nucleic acid purification elution step, 
inclusion of an internal positive control for nucleic acid puri-
fication and detection, and concurrent detection and analysis 
of BTV and EHDV in a single reaction, which reduces test-
ing costs. In addition, inclusion of the internal control reduces 
the potential of reporting false-negative results due to system 
and human error, thus providing more confidence in the 
results. The described automated nucleic acid purification 
method is also the universal pathogen nucleic acid purifica-
tion method that is used for diverse biological samples that are 
submitted for testing at TVMDL, thus enabling sample batch-
ing and minimizing labor, equipment, and consumables usage.
The utility of this workflow was demonstrated in the rou-
tine diagnostic testing of approximately 3,043 samples sub-
mitted to TVMDL during a 1-year period. Of the 376 positive 
samples identified, 41% (157/376) were BTV-only positives, 
47% (176/376) were EHDV-only positives, and, interest-
ingly, 11.4% (43/376) were both BTV and EHDV–positive 
coinfections.
There have been several reports in the literature of natural 
BTV and EHDV coinfections, multiple BTV serotype coin-
fections, and BTV or EHDV reassortants in both cattle and 
sheep,28,39,42 as well as in the insect vector.29 Multiple reports 
from India have detected BTV reassortments in sheep 
between BTV-16 and BTV-21,32 BTV-3 eastern and west-
ern,21 BTV-2 eastern and western,22 and BTV-23 eastern and 
western topotypes.23 In the United States, a BTV reassortant 
that included genes from BTV-2 and BTV-6 was reported in 
a cow with BTV clinical disease.26 Epizootic hemorrhagic 
disease virus reassortants, such as an EHDV-6 (Indiana) that 
contained genes from endemic EHDV-2 (Alberta) and exotic 
EHDV-6 (Australia) serotypes, was first recovered from 
dead white-tailed deer in Indiana and Illinois in 2006.1 In 
addition to reassortants, dual BTV serotype coinfections 
have also been reported: BTV-1 and BTV-12, BTV-3 and 
BTV-24, and BTV-22 and BTV-24, in several cattle with no 
clinical signs of disease in Kenya,39 and BTV-4 and BTV-16, 
and BTV-4 and BTV-24 in 2 different cows, respectively, 
with BTV clinical signs in Israel.7 Because several of these 
reports identified multiple BTV serotype coinfections in ani-
mals with and without clinical signs, the significance of BTV 
serotype coinfections in disease manifestation is currently 
unclear. Other factors such as breed and age may play a role 
in disease presentation. Several of the reports7,39,46 do, how-
ever, speculate that these reassortants may be more virulent 
than the parental serotypes and may therefore be responsible 
for the increased virulence observed in diseased animals. 
However, additional studies are needed to verify this assump-
tion.
With regard to BTV and EHDV coinfections, an investi-
gation of the Reunion Island cattle population consisting of 
116 cows exhibiting BTV and EHDV clinical signs reported 
a 4% (5/116 total blood samples tested) BTV-2–EHDV-6 
coinfection rate.28 Because 91% of this cattle population 
were EHDV-6–only positive, and the coinfected cattle were 
infected with BTV-2, which, according to the authors, has 
never caused clinical signs, the authors speculate that the 
clinical signs displayed in the BTV-2 and EHDV-6 coin-
fected cattle may be a result of EHDV-6. In this report,28 
BTV-only infections were not detected. Another report iden-
tified a 58.6% coinfection rate (58/99 total cow blood sam-
ples tested) in nondiseased cows in Kenya.39 In the current 
study, BTV and EHDV coinfections were identified in cattle 
at a rate of 1.49% (34/2,285 total bovine samples tested), and 
in white-tailed deer (cervine) at a rate of 1.46% (9/615 total 
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cervine samples tested). Two of the 34 coinfected cattle 
exhibited clinical disease and were from farms reporting a 
BTV and/or EHDV outbreak; 5 of 9 coinfected white-tailed 
deer exhibited clinical disease; and the remaining coinfected 
samples lacked disease information, thus disease correlation 
with these coinfections is unknown. Based on the available 
published literature, the current study has evaluated the high-
est number of animals for BTV and EHDV coinfections thus 
far in a U.S. sampled population. The importance of these 
coinfections in the transmission and virulence of these 
viruses is currently unknown, as there are neither reports of 
reassortment events between BTV and EHDV, nor reports of 
exacerbated clinical disease with coinfections. Nevertheless, 
these coinfections may be important in understanding dis-
ease presentations. Similarly, coinfections among multiple 
BTV serotypes or multiple EHDV serotypes may be impor-
tant in virus transmission as they create opportunities for 
potential interaction between several BTV or EHDV sero-
types that can potentially result in the generation of newer, 
more virulent BTV or EHDV serotypes.6,33,38 The potential 
emergence of new virulent serotypes or the invasion of sero-
types previously unseen in certain geographic locations 
therefore emphasizes the need for rapid identification and 
differentiation of these 2 viruses that present similar clinical 
signs.
In summary, a streamlined workflow that includes an 
innovative automated dsRNA denaturation during nucleic 
acid purification, followed by the simultaneous detection of 
BTV and EHDV by mRT-qPCR, has been developed. This 
workflow provides rapid, reliable results, and reduces the 
potential for contamination and human error by eliminating 
the separate denaturation step commonly used to denature 
BTV and EHDV dsRNA. Implementation and ongoing use 
of this workflow has enabled detection of single and dual 
infections in diverse samples for regulatory testing, herd 
health management, and differential disease diagnosis. The 
simultaneous and differential detection of BTV and EHDV 
provides significant benefits for 2 important ruminant dis-
eases with similar clinical presentations, particularly in light 
of reports of BTV- and EHDV-associated clinical disease in 
cattle.
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Supplemental Figure 1. Automated 95°C denaturation versus the separate thermal cycler 95°C 
denaturation of Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) 
purified RNA. BTV- and/or EHDV-positive samples (90 total; 20 bovine blood BTV-positive 
only, 37 EHDV-positive only [(14 blood, 23 tissue)], and 33 BTV and EHDV [(30 blood, 3 
tissue)]) were purified and detected using the Texas A&M Veterinary Medical Diagnostic 
Laboratory (TVMDL) workflow, which consisted of an automated nucleic acid purification and 
then a multiplex reverse transcription quantitative polymerase chain reaction (mRT-qPCR) 
assay. Samples were either denatured at 95°C during the automated elution step, immediately 
denatured at 95°C for 5 min on a thermal cycler following nucleic acid purification, or not 
denatured following nucleic acid purification and tested by mRT-qPCR. A, BTV assay; B, 
EHDV assay. Cq = quantitation cycle. 


